Summary

The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period. Factors such as decline in the fertility rates worldwide, increase adoption of different infertility procedures, rising number of fertility clinics worldwide, rise in public & private investments and presence of advanced infertility treatment products in the market are anticipated to boost the growth of the market.

The recent COVID-19 global pandemic has also impacted the infertility treatment market. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.
“The equipment to capture the largest share in infertility treatment market, by products during the forecast period.”
The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the technological advancements and presence of well-established players with strong product portfolio. Along with this growing focus of players towards base expansion through adopting various strategies such as new equipment launch, showcase across the globe is likely to contribute towards the growth of the segment.
“The assisted reproductive technology (ART) to capture the largest market share of infertility treatment market, by the procedure in 2021.”
The assisted reproductive technology segment captured the largest share of the infertility treatment market procedures during the forecast period. The growing awareness of the presence of ART, rise in success rate of this procedure and growing worldwide acceptance of ART is likely to boost the growth of the segment.
“The female infertility treatment segment commanded for the largest share of the infertility treatment market, by patient type, in 2021”
The decreasing rates of fertility among females, growing availability of various fertility treatment options, and the increasing number of fertility centers across the globe are driving the growth of the female infertility treatment market.

“The fertility centers segment accounted for the largest share of the infertility treatment market, by end user, in 2021”
The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, and the increasing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.


“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The infertility treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the awareness of availability of infertility treatment procedures, growing fertility centers in the region, rising healthcare expenditures, increasing patient population, growing medical tourism, improving healthcare expenditure on infertility treatment, and initiatives by the government to increase the accessibility of the infertility treatment in the emerging nations.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%




The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US).

Research Coverage
This report studies the global infertility treatment market based on the product, procedure, patient type, end users, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global infertility treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 YEARS CONSIDERED FOR THE STUDY 34
1.4 CURRENCY USED FOR THE STUDY 34
1.5 MAJOR MARKET STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Secondary sources 38
2.1.2 PRIMARY DATA 38
FIGURE 2 BREAKDOWN OF PRIMARIES: INFERTILITY TREATMENT MARKET 39
2.2 MARKET ESTIMATION METHODOLOGY 39
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 40
2.2.2 USAGE-BASED MARKET ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON PRODUCT UTILIZATION METHODOLOGY 41
FIGURE 5 MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON REVENUE MAPPING METHODOLOGY 42
2.2.3 PRIMARY RESEARCH VALIDATION 42
2.3 DATA TRIANGULATION 43
FIGURE 6 DATA TRIANGULATION METHODOLOGY 43
2.4 RESEARCH ASSUMPTIONS 44
2.5 RESEARCH LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
FIGURE 7 INFERTILITY TREATMENT MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 45
FIGURE 8 INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 46
FIGURE 9 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2021 VS. 2026 (USD MILLION) 47
FIGURE 10 INFERTILITY TREATMENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 48
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET 49
4 PREMIUM INSIGHTS 50
4.1 INFERTILITY TREATMENT MARKET OVERVIEW 50
FIGURE 12 DECLINING FERTILITY RATE AND RISING NUMBER OF FERTILITY CLINICS WORLDWIDE TO DRIVE MARKET GROWTH 50
4.2 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 51
FIGURE 13 MEDIA & CONSUMABLES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD 51
4.3 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION) 52
FIGURE 14 ASSISTED REPRODUCTIVE TECHNOLOGY IS THE LARGEST PROCEDURE SEGMENT OF THE INFERTILITY TREATMENT MARKET 52
4.4 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION) 53
FIGURE 15 MALE INFERTILITY TREATMENT SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 53
4.5 INFERTILITY TREATMENT MARKET SHARE, BY END USER, 2021 54
FIGURE 16 FERTILITY CENTERS ARE THE LARGEST END USERS OF INFERTILITY TREATMENT PRODUCTS 54
4.6 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT AND COUNTRY (2021) 55
FIGURE 17 EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC INFERTILITY TREATMENT MARKET IN 2021 55
FIGURE 18 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026) 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 19 INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Declining fertility rate 58
FIGURE 20 DECLINING GLOBAL FERTILITY RATE, BY REGION, 1990 VS. 2019 VS. 2030 58
FIGURE 21 RISING OBESITY RATES (PERCENTAGE OF THE US POPULATION):
2010 VS. 2030 59
5.2.1.2 Rising number of fertility clinics worldwide 60
5.2.1.3 Technological advancements 60
5.2.1.3.1 Advancements in infertility treatment devices 60
5.2.1.3.2 Increasing use of time-lapse technology worldwide 61
5.2.1.4 Increasing public-private investments, funds, and grants 61
5.2.2 RESTRAINTS 62
5.2.2.1 High costs associated with assisted reproductive technology in developed markets 62
TABLE 1 INFERTILITY TREATMENT COSTS 62
5.2.2.2 Unsupportive government regulations 63

5.2.3 OPPORTUNITIES 64
5.2.3.1 Growth opportunities in emerging markets 64
5.2.3.1.1 Improving healthcare infrastructure 64
5.2.3.2 Increasing medical tourism due to low treatment costs 64
5.2.3.3 Use of fertility treatment options by single parents and same-sex couples 65
5.2.4 CHALLENGES 65
5.2.4.1 Concerns related to ART procedures 65
5.2.4.2 Reduced efficacy among older women 66
5.3 REGULATORY LANDSCAPE 66
5.3.1 NORTH AMERICA 66
5.3.1.1 US 66
5.3.1.2 Canada 67
5.3.2 EUROPE 67
5.3.3 ASIA PACIFIC 67
5.3.3.1 India 67
5.3.3.2 Japan 67
TABLE 2 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 68
5.4 COVID-19 IMPACT ON THE INFERTILITY TREATMENT MARKET 68
5.5 VALUE CHAIN ANALYSIS 69
FIGURE 22 VALUE CHAIN OF THE INFERTILITY TREATMENT MARKET 69
5.6 PRICING TREND ANALYSIS 70
TABLE 3 AVERAGE PRICE OF INFERTILITY TREATMENT EQUIPMENT AND MEDIA,
BY COUNTRY, 2020 (USD) 70
5.7 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 4 INFERTILITY TREATMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 71
5.7.1 THREAT OF NEW ENTRANTS 71
FIGURE 23 THREAT OF NEW ENTRANTS 72
5.7.2 THREAT OF SUBSTITUTES 72
FIGURE 24 THREAT OF SUBSTITUTES 72
5.7.3 BARGAINING POWER OF SUPPLIERS 73
FIGURE 25 BARGAINING POWER OF SUPPLIERS 73
5.7.4 BARGAINING POWER OF BUYERS 73
FIGURE 26 BARGAINING POWER OF BUYERS 73
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 74
FIGURE 27 INTENSITY OF COMPETITIVE RIVALRY 74
5.8 ECOSYSTEM COVERAGE 74

6 INFERTILITY TREATMENT MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 5 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 76
6.1.1 EQUIPMENT 76
TABLE 6 INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 77
TABLE 7 INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 77
6.2 MICROSCOPES 78
6.2.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF MICROSCOPY HAS RESULTED IN THE GROWING ADOPTION OF MICROSCOPES 78
TABLE 8 MICROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 78
TABLE 9 MICROSCOPES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 79
TABLE 10 MICROSCOPES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 79
TABLE 11 MICROSCOPES MARKET, BY END USER, 2019–2026 (USD MILLION) 80
6.2.2 IMAGING SYSTEMS 80
6.2.2.1 Advantages offered by imaging systems in the field of infertility treatment are driving their adoption 80
TABLE 12 IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 81
TABLE 13 IMAGING SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 81
TABLE 14 IMAGING SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 82
TABLE 15 IMAGING SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 82
6.2.3 SPERM ANALYZER SYSTEMS 82
6.2.3.1 Sperm analyzer systems have a wide range of applications in fertility screening 82
TABLE 16 SPERM ANALYZER SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 83
TABLE 17 SPERM ANALYZER SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 83
TABLE 18 SPERM ANALYZER SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 84
TABLE 19 SPERM ANALYZER SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION) 84
6.2.4 OVUM ASPIRATION PUMPS 84
6.2.4.1 Ovum aspiration pumps are widely used to retrieve and protect oocytes 84
TABLE 20 OVUM ASPIRATION PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION) 85
TABLE 21 OVUM ASPIRATION PUMPS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 85
TABLE 22 OVUM ASPIRATION PUMPS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 86
TABLE 23 OVUM ASPIRATION PUMPS MARKET, BY END USER,
2019–2026 (USD MILLION) 86
6.2.5 MICROMANIPULATOR SYSTEMS 86
6.2.5.1 Micromanipulator systems are used in cases pertaining to poor sperm quality/mobility 86
TABLE 24 MICROMANIPULATOR SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 87
TABLE 25 MICROMANIPULATOR SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 88
TABLE 26 MICROMANIPULATOR SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 88
TABLE 27 MICROMANIPULATOR SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION) 89
6.2.6 INCUBATORS 89
6.2.6.1 Incubators play a vital role in embryo development and improved clinical outcomes 89
TABLE 28 INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 90
TABLE 29 INCUBATORS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 90
TABLE 30 INCUBATORS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 91
TABLE 31 INCUBATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 91
6.2.7 GAS ANALYZERS 91
6.2.7.1 Gas analyzers contain multiple ports enabling analysis of sequential gas samples 91
TABLE 32 GAS ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 33 GAS ANALYZERS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 92
TABLE 34 GAS ANALYZERS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 93
TABLE 35 GAS ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION) 93
6.2.8 LASER SYSTEMS 93
6.2.8.1 Common applications of laser systems include the treatment of stress urinary incontinence and vaginal tightening 93
TABLE 36 LASER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 94
TABLE 37 LASER SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 94
TABLE 38 LASER SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 95
TABLE 39 LASER SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 95
6.2.9 CRYOSYSTEMS 95
6.2.9.1 Demand for cryosystems is on the rise as women are seeking to extend their childbearing years 95
TABLE 40 CRYOSYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 96
TABLE 41 CRYOSYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 96
TABLE 42 CRYOSYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 97
TABLE 43 CRYOSYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 97
6.2.10 SPERM SEPARATION DEVICES 98
6.2.10.1 Introduction of advanced sperm separation devices to boost their adoption 98
TABLE 44 SPERM SEPARATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 98
TABLE 45 SPERM SEPARATION DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 99
TABLE 46 SPERM SEPARATION DEVICES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 99
TABLE 47 SPERM SEPARATION DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 100
6.3 MEDIA & CONSUMABLES 100
6.3.1 EASY AVAILABILITY OF CULTURE MEDIA TO SUPPORT MARKET GROWTH 100
TABLE 48 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 101
TABLE 49 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 101
TABLE 50 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 102
TABLE 51 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY END USER, 2019–2026 (USD MILLION) 102
6.4 ACCESSORIES 103
6.4.1 ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES 103
TABLE 52 INFERTILITY TREATMENT ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 103
TABLE 53 INFERTILITY TREATMENT ACCESSORIES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 104
TABLE 54 INFERTILITY TREATMENT ACCESSORIES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 104
TABLE 55 INFERTILITY TREATMENT ACCESSORIES MARKET, BY END USER,
2019–2026 (USD MILLION) 105
7 INFERTILITY TREATMENT MARKET, BY PROCEDURE 106
7.1 INTRODUCTION 107
TABLE 56 INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 107
7.2 ASSISTED REPRODUCTIVE TECHNOLOGY 107
TABLE 57 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 108
TABLE 58 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 108
7.2.1 IN VITRO FERTILIZATION 108
FIGURE 28 UK: IVF BIRTH RATES, 2010–2019 109
TABLE 59 IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 60 IN VITRO FERTILIZATION MARKET, BY REGION, 2019–2026 (USD MILLION) 110
7.2.1.1 Intracytoplasmic morphologically selected sperm injection 110
7.2.1.1.1 IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure 110
TABLE 61 INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION MARKET, BY REGION, 2019–2026 (USD MILLION) 111
7.2.1.2 Gamete donation 111
7.2.1.2.1 Increasing number of women registering as egg donors is a key factor aiding market growth 111
TABLE 62 GAMETE DONATION MARKET, BY REGION, 2019–2026 (USD MILLION) 112
7.2.2 INTRACYTOPLASMIC SPERM INJECTION 112
7.2.2.1 ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures 112
TABLE 63 INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION,
2019–2026 (USD MILLION) 113
7.2.3 SURROGACY 113
7.2.3.1 High success rates guaranteed and achieved with the help of surrogacy are driving market growth 113
TABLE 64 SURROGACY MARKET, BY REGION, 2019–2026 (USD MILLION) 114
7.3 ARTIFICIAL INSEMINATION 114
TABLE 65 ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 66 ARTIFICIAL INSEMINATION MARKET, BY REGION, 2019–2026 (USD MILLION) 115
7.3.1 INTRAUTERINE INSEMINATION 116
7.3.1.1 Limited risk of complications during pregnancy and high success rate are driving the market for IUI procedures 116
TABLE 67 INTRAUTERINE INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION) 116
7.3.2 INTRACERVICAL INSEMINATION 117
7.3.2.1 Low cost of this procedure as compared to other AI procedures to support market growth 117
TABLE 68 INTRACERVICAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION) 117
7.3.3 INTRATUBAL INSEMINATION 117
7.3.3.1 High cost and uncertain success rate of this procedure to restrain the market growth 117
TABLE 69 INTRATUBAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION) 118
7.4 FERTILITY SURGERIES 118
TABLE 70 FERTILITY SURGERIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 71 FERTILITY SURGERIES MARKET, BY REGION, 2019–2026 (USD MILLION) 119
7.4.1 LAPAROSCOPY 119
7.4.1.1 Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility 119
TABLE 72 LAPAROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION) 120
7.4.2 HYSTEROSCOPY 120
7.4.2.1 Growing demand for minimally invasive procedures is driving the adoption of hysteroscopy infertility treatment surgeries globally 120
TABLE 73 HYSTEROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION) 121
7.4.3 MYOMECTOMY 121
7.4.3.1 Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery 121
TABLE 74 MYOMECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 122
7.4.4 LAPAROTOMY 122
7.4.4.1 Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system 122
TABLE 75 LAPAROTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 122
7.4.5 TUBAL LIGATION REVERSAL 123
7.4.5.1 Tubal ligation reversal is performed in women who still have a large portion of healthy fallopian tube remaining 123
TABLE 76 TUBAL LIGATION REVERSAL MARKET, BY REGION,
2019–2026 (USD MILLION) 123
7.4.6 VARICOCELECTOMY 124
7.4.6.1 Varicocelectomy results in a high chance of improved fertility with reduced complications 124
TABLE 77 VARICOCELECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 124
7.4.7 MICROSURGICAL RECONSTRUCTION 124
TABLE 78 MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 79 MICROSURGICAL RECONSTRUCTION MARKET, BY REGION,
2019–2026 (USD MILLION) 125
7.4.7.1 Vasovasostomy 125
7.4.7.1.1 Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men 125
TABLE 80 VASOVASOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 126
7.4.7.2 Vasoepididymostomy 126
7.4.7.2.1 Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI 126
TABLE 81 VASOEPIDIDYMOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 127
7.5 OTHER INFERTILITY TREATMENT PROCEDURES 127
TABLE 82 OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION,
2019–2026 (USD MILLION) 128
8 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE 129
8.1 INTRODUCTION 130
TABLE 83 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 130
8.2 FEMALE INFERTILITY TREATMENT 130
8.2.1 INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET 130
FIGURE 29 US: IVF SUCCESS RATES BY AGE FOR ALL IVF CYCLES, 2019 131
TABLE 84 FEMALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 131
8.3 MALE INFERTILITY TREATMENT 132
8.3.1 GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO DRIVE MARKET GROWTH 132
TABLE 85 MALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 132

9 INFERTILITY TREATMENT MARKET, BY END USER 133
9.1 INTRODUCTION 134
TABLE 86 INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION) 134
9.2 FERTILITY CENTERS 134
9.2.1 GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE TO DRIVE MARKET GROWTH 134
TABLE 87 INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY REGION, 2019–2026 (USD MILLION) 135
9.3 HOSPITALS & SURGICAL CLINICS 135
9.3.1 GOVERNMENT INITIATIVES TO INCREASE HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES IS SUPPORTING MARKET GROWTH 135
TABLE 88 INFERTILITY TREATMENT MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2019–2026 (USD MILLION) 136
9.4 CRYOBANKS 136
9.4.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT TO DRIVE MARKET GROWTH 136
TABLE 89 INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION,
2019–2026 (USD MILLION) 137
9.5 RESEARCH INSTITUTES 137
9.5.1 GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS TO DRIVE MARKET GROWTH 137
TABLE 90 INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 138
10 INFERTILITY TREATMENT MARKET, BY REGION 139
10.1 INTRODUCTION 140
TABLE 91 INFERTILITY TREATMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 140
10.2 ASIA PACIFIC 140
TABLE 93 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 142
TABLE 94 ASIA PACIFIC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 95 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 143
TABLE 96 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 97 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 98 ASIA PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 99 ASIA PACIFIC: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 100 ASIA PACIFIC: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 101 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 146
TABLE 102 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.2.1 CHINA 147
10.2.1.1 Declining birth rate in China to drive the demand for infertility treatment procedures in the country 147
TABLE 103 CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 104 CHINA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
10.2.2 JAPAN 148
10.2.2.1 Growing awareness has served to boost the adoption of IVF procedures in Japan 148
TABLE 105 JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 149
TABLE 106 JAPAN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
10.2.3 INDIA 150
10.2.3.1 Rising medical tourism to offer high-growth opportunities for players in the Indian infertility treatment market 150
TABLE 107 INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 108 INDIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
10.2.4 AUSTRALIA 152
10.2.4.1 Initiatives by the Australian government to support market growth 152
TABLE 109 AUSTRALIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 153
TABLE 110 AUSTRALIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
10.2.5 SOUTH KOREA 154
10.2.5.1 Supportive government initiatives will positively impact market growth 154
TABLE 111 SOUTH KOREA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 112 SOUTH KOREA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
10.2.6 REST OF ASIA PACIFIC 155
TABLE 113 ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 114 ROAPAC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
10.3 EUROPE 157
TABLE 115 EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
TABLE 116 EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 158
TABLE 117 EUROPE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 118 EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 159
TABLE 119 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 120 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 121 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 122 EUROPE: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 123 EUROPE: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 124 EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 162
TABLE 125 EUROPE: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 162
10.3.1 GERMANY 162
10.3.1.1 Favorable funding scenario for IVF treatments in Germany to drive market growth 162
TABLE 126 GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 127 GERMANY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
10.3.2 UK 164
10.3.2.1 Supportive regulatory framework in the UK to drive market growth 164
FIGURE 31 UK: NUMBER OF IVF CYCLES BY EGG AND SPERM SOURCE, 2010-2019 165
TABLE 128 UK: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 165
TABLE 129 UK: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
10.3.3 FRANCE 166
10.3.3.1 Rising healthcare spending in France to drive market growth 166
TABLE 130 FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 167
TABLE 131 FRANCE: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 168
10.3.4 ITALY 168
10.3.4.1 Decreasing fertility rates to drive the demand for fertility testing treatment procedures in Italy 168
TABLE 132 ITALY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 133 ITALY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
10.3.5 SPAIN 170
10.3.5.1 Spain is an established destination for IVF tourism 170
TABLE 134 SPAIN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 135 SPAIN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
10.3.6 REST OF EUROPE 171
TABLE 136 ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 172
TABLE 137 ROE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
10.4 NORTH AMERICA 173
TABLE 138 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 173
TABLE 139 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 140 NORTH AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 141 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 174
TABLE 142 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 143 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 144 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 145 NORTH AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 146 NORTH AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 147 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 177
TABLE 148 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 178
10.4.1 US 178
10.4.1.1 The US dominates the infertility treatment market in North America 178
TABLE 149 US: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 179
TABLE 150 US: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
10.4.2 CANADA 180
10.4.2.1 High cost of infertility treatment in the country to restrain the market growth 180
TABLE 151 CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 181
TABLE 152 CANADA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
10.5 LATIN AMERICA 182
TABLE 153 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 182
TABLE 154 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 182
TABLE 155 LATIN AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 156 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 183
TABLE 157 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 158 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 159 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 160 LATIN AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 161 LATIN AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 162 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 186
TABLE 163 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 187
10.5.1 BRAZIL 187
10.5.1.1 Brazil holds the largest share of the Latin American infertility treatment market 187
TABLE 164 BRAZIL: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 187
TABLE 165 BRAZIL: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
10.5.2 MEXICO 188
10.5.2.1 Growth in medical tourism is a key factor driving market growth 188
TABLE 166 MEXICO: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 189
TABLE 167 MEXICO: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
10.5.3 REST OF LATIN AMERICA 190
TABLE 168 ROLATAM: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 190
TABLE 169 ROLATAM: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
10.6 MIDDLE EAST & AFRICA 191
10.6.1 RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 191
TABLE 170 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 192
TABLE 171 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 172 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 193
TABLE 173 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 174 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 175 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 176 MIDDLE EAST & AFRICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 177 MIDDLE EAST & AFRICA: MICROSURGICAL RECONSTRUCTION MARKET,
BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 178 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 196
TABLE 179 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION) 197
11 COMPETITIVE LANDSCAPE 198
11.1 OVERVIEW 198
11.2 KEY PLAYER STRATEGIES 198
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 199
FIGURE 32 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET 199
11.4 MARKET SHARE ANALYSIS (2020) 199
TABLE 180 INFERTILITY TREATMENT MARKET: DEGREE OF COMPETITION 199
11.5 COMPETITIVE LEADERSHIP MAPPING 201
11.5.1 STARS 201
11.5.2 PERVASIVE PLAYERS 201
11.5.3 EMERGING LEADERS 201
11.5.4 PARTICIPANTS 202
FIGURE 33 INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP
MAPPING, 2020 202
11.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020) 203
11.6.1 PROGRESSIVE COMPANIES 203
11.6.2 STARTING BLOCKS 203
11.6.3 RESPONSIVE COMPANIES 203
11.6.4 DYNAMIC COMPANIES 203
FIGURE 34 INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020 204
11.7 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET 205
11.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET 205
TABLE 181 PRODUCT FOOTPRINT OF COMPANIES 206
11.8 COMPETITIVE SCENARIO 208
11.8.1 INFERTILITY TREATMENT MARKET: PRODUCT LAUNCHES AND
REGULATORY APPROVALS 208
TABLE 183 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS, JANUARY
2018–SEPTEMBER 2021 208
11.8.2 INFERTILITY TREATMENT MARKET: DEALS 208
TABLE 184 KEY DEALS, JANUARY 2018–SEPTEMBER 2021 208
11.8.3 INFERTILITY TREATMENT MARKET: OTHER DEVELOPMENTS 209
TABLE 185 OTHER KEY DEVELOPMENTS, JANUARY 2018–SEPTEMBER 2021 209
12 COMPANY PROFILES 210
12.1 MAJOR PLAYERS 210
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THE COOPER COMPANIES INC. 210
TABLE 186 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW 210
FIGURE 35 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020) 211
TABLE 187 THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS 212
12.1.2 COOK GROUP 214
TABLE 188 COOK GROUP: BUSINESS OVERVIEW 214
TABLE 189 COOK GROUP: PRODUCT OFFERINGS 214
12.1.3 VITROLIFE 216
TABLE 190 VITROLIFE: BUSINESS OVERVIEW 216
FIGURE 36 VITROLIFE: COMPANY SNAPSHOT (2020) 217
TABLE 191 VITROLIFE: PRODUCT OFFERINGS 218
12.1.4 THERMO FISHER SCIENTIFIC 220
TABLE 192 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 220
FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 221
TABLE 193 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 222
12.1.5 HAMILTON THORNE LTD. 224
TABLE 194 HAMILTON THORNE LTD.: BUSINESS OVERVIEW 224
FIGURE 38 HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020) 224
TABLE 195 HAMILTON THORNE LTD.: PRODUCT OFFERINGS 225
12.1.6 ESCO MICRO PTE. LTD. 227
TABLE 196 ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW 227
TABLE 197 ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS 227
12.1.7 GENEA LIMITED 229
TABLE 198 GENEA LIMITED: BUSINESS OVERVIEW 229
TABLE 199 GENEA LIMITED: PRODUCT OFFERINGS 229
12.1.8 IVFTECH APS 231
TABLE 200 IVFTECH APS: BUSINESS OVERVIEW 231
TABLE 201 IVFTECH APS: PRODUCT OFFERINGS 231
12.1.9 FUJIFILM IRVINE SCIENTIFIC 232
TABLE 202 FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW 232
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020) 232
TABLE 203 FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS 233
12.1.10 THE BAKER COMPANY, INC. 235
TABLE 204 THE BAKER COMPANY, INC.: BUSINESS OVERVIEW 235
TABLE 205 THE BAKER COMPANY, INC.: PRODUCT OFFERINGS 235
12.1.11 KITAZATO CORPORATION 236
TABLE 206 KITAZATO CORPORATION: BUSINESS OVERVIEW 236
TABLE 207 KITAZATO CORPORATION: PRODUCT OFFERINGS 236
12.1.12 ROCKET MEDICAL PLC 238
TABLE 208 ROCKET MEDICAL PLC: BUSINESS OVERVIEW 238
TABLE 209 ROCKET MEDICAL PLC: PRODUCT OFFERINGS 238
12.1.13 IHMEDICAL A/S 239
TABLE 210 IHMEDICAL A/S: BUSINESS OVERVIEW 239
TABLE 211 IHMEDICAL A/S: PRODUCT OFFERINGS 239
12.1.14 ZEISS GROUP 240
TABLE 212 ZEISS GROUP: BUSINESS OVERVIEW 240
FIGURE 40 ZEISS GROUP: COMPANY SNAPSHOT (2020) 241
TABLE 213 ZEISS GROUP: PRODUCT OFFERINGS 241
12.1.15 MEDGYN PRODUCTS, INC. 242
TABLE 214 MEDGYN PRODUCTS, INC.: BUSINESS OVERVIEW 242
TABLE 215 MEDGYN PRODUCTS, INC.: PRODUCT OFFERINGS 242
12.2 OTHER PLAYERS 234
12.2.1 DXNOW, INC. 234
12.2.2 NIDACON INTERNATIONAL AB 235
12.2.3 GYNOTEC B.V. 235
12.2.4 SAR HEALTHLINE PVT. LTD. 236
12.2.5 INVITROCARE INC. 237
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 247
13.1 DISCUSSION GUIDE 247
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 251
13.3 AVAILABLE CUSTOMIZATIONS 253
13.4 RELATED REPORTS 254
13.5 AUTHOR DETAILS 255